Moreover, risedronate, an anti-osteoporosis drug, decreased the distance of tooth movement in OVX rats and simultaneously decreased the number of IL-20-positive cells and TRAP-positive osteoclasts (Figure 1G–J). This evidence concerns the gene IL20 and osteoporosis.